AliveCor introduces the world's first AI that can detect heart attack on a reduced leadset in monumental dual clearance by the FDA. Today, AliveCor launched the all-new, AI-powered Kardia 12L ECG System, which is FDA-cleared to detect 35 cardiac conditions including serious conditions like acute myocardial infarction (MI) and the most common types of cardiac ischemia. The 12-lead ECG has been the standard of cardiac care since 1954, but its availability has been limited. Until now. Small enough to fit in a pocket, Kardia 12L boasts advanced AI algorithms that are substantially equivalent to the current state-of-the-art ECG analysis solutions. Learn how Kardia 12L can assist physicians in rapid disease detection, enhance patient experience, and expand access to accurate heart data faster and more conveniently than ever before. prnewswire.com/news-releases…

🚀 AliveCor is exhibiting at the WELL Health Diagnostic Centres CME Event on Saturday, September 26th. Kick off your morning with us: ⏰ 9:00 AM | Special remarks by Dr. Ben Green, Chief Clinical Officer at AliveCor. After the presentation, visit our exhibit table to: ✅ Experience live demonstrations of our AI-driven ECG technology. ✅ Explore how remote cardiac monitoring integrates into diagnostic practice. ✅ Connect directly with our clinical and product teams. Are you attending? Drop a comment below or stop by our booth. 🔗 Agenda details: welldiagnostics.ca/cme/ #Cardiology #DigitalHealth #AliveCor #HealthTech #RemotePatientMonitoring #MedEd

We are proud to support the #kumpelherz initiative at the upcoming @s04_en home game on September 20th! 💙⚽ Our goal? Perform over 4,000 ECG screenings right at the stadium using KardiaMobile 6L technology and smartwatch data. In just 30 seconds, fans can take a medical-grade ECG—bringing atrial fibrillation (AFib) detection directly to the football community where it matters most. Together, we’re putting heart health at the center of game day. 🫀⚡ 📰 Read more about the campaign covered by WDR: www1.wdr.de/nrw/ruhrgebiet/g… #kumpelherz #vorhofflimmern #bundesliga #ecg #prevention #AliveCor #KardiaMobile #DigitalHealth #StrokePrevention #Cardiology

Conduction system pacing (CSP) offers the promise of true physiologic activation—yet reliably confirming capture and optimizing programming remains one of the field’s most pressing challenges. 💡🫀 Join us at HRX 2026 for an elite roundtable discussion powered by AliveCor: 📌 Advances in Optimizing Conduction System Pacing 📅 Date: Saturday, September 19, 2026 ⏰ Time: 8:50 AM – 9:35 AM EDT 📍 Location: Roundtable 3 Moderated by Dr. Eugene Chung (Massachusetts General Hospital / Harvard Medical School), this session features an outstanding panel of key opinion leaders debating procedural success, signal verification, and how advanced tools can drive durable clinical benefits for patients: • Dr. Neal Bhatia (Emory) • Dr. Mikhael El-Chami (Emory) • Dr. Daniel Frisch (Thomas Jefferson University) • Dr. Nino Isakadze (Johns Hopkins) • Dr. Ajay Pillai (VCU Health) • Dr. Alan Sugrue (Mayo Clinic) • Dr. Pugazhendhi Vijayaraman (Geisinger Heart & Vascular Institute) 👉 Don't miss this high-impact discussion on the future of EP innovation: experiencehrx.com/event/adva… #HRX2026 #HeartRhythm #Electrophysiology #AliveCor #ConductionSystemPacing #Cardiology #MedTech

Introducing KardiaACCESS: A Medicare-Covered Program Built to Improve Blood Pressure, Diabetes, and Heart Health. Under the new CMS ACCESS Model, eligible Original Medicare beneficiaries can receive clinician-guided care and medical-grade connected tools at $0 out-of-pocket cost. Key highlights of KardiaACCESS: 🌐 $0 Cost: Fully covered with no co-pays, no deductibles, and no hidden fees for qualifying Original Medicare (Part B) beneficiaries. 🩺 Comprehensive Focus: Supports the complete Cardio-Kidney-Metabolic (CKM) system as a whole. 📲 Connected Support: Includes connected devices, active clinical progress checks, virtual care visits, lifestyle coaching, and doctor-ready reports. Now live in 48 states. 👇 Explore the program: globenewswire.com/news-relea… #AliveCor #Medicare #DigitalHealth #RemoteMonitoring #HealthEquity #Cardiology

🚀 𝟰𝟬𝟬,𝟬𝟬𝟬,𝟬𝟬𝟬 𝗘𝗖𝗚𝘀 𝗿𝗲𝗰𝗼𝗿𝗱𝗲𝗱. This vast, medical-grade heart data fuels the development of our next-generation AI algorithms, accelerating innovation in cardiac care. As #AFibAwarenessMonth begins, every single one of these recordings represents a step forward in detecting silent heart conditions like Atrial Fibrillation before complications arise. This achievement is a powerful testament to the trust placed in our technology. To our patients, providers, and partners around the world — thank you. Your continued confidence drives us to improve patient outcomes every day. Here’s to impacting millions more lives. 💙 #AFibAwarenessMonth #CardiacCare #HeartHealth #AIinHealthcare #DigitalHealth

Honorary doctorate or not, we’ll take an 8/10 from @MKBHD any day! 🩺⚡ In his new video "I Said Yes to Every Email for a Month! (Again)", Marques took a look at the KardiaMobile 6L Max, highlighting how it puts medical-grade EKG technology right at your fingertips. Huge thanks to Marques and the team for putting KardiaMobile 6L Max to the test. 🎥 Watch the clip here: youtube.com/watch?v=mfmdXPT7… #AliveCor #MKBHD #TechReview #HeartCare #SmartHealth #Cardiology #HealthTech #Kardia

As consumer wellness wearables flood the market, the line between lifestyle tracking and clinical diagnostics is blurring. 📰 In a new op-ed for @medcitynews, AliveCor Founder & Chief Medical Officer @DrDave01 breaks down the FDA’s latest guidance on "general wellness" products—and why distinguishing consumer tech from medical-grade, clinically validated devices is critical for patient safety. "When using general wellness tools, they are consumers. When using medical-grade tools, they’re patients. I want people to know when they become patients." 🔗 Read the full article to see why medical-grade precision matters now more than ever: medcitynews.com/2026/08/the-… #DigitalHealth #MedTech #Cardiology #PatientSafety #AliveCor

Peer-reviewed research published in #JACCAdvances reveals a clear advantage in arrhythmia detection when monitoring is patient-initiated. 🩺 A landmark study by the University of Rochester Clinical Cardiovascular Research Center (350 patients) found that 30-day use of KardiaMobile 6L nearly doubled the diagnostic yield compared to traditional continuous ambulatory monitoring (14.9% vs. 7.7%, p < 0.001). 📈 Key clinical findings: 🎯 39 arrhythmia episodes (11.1%) were detected exclusively by KardiaMobile 6L and missed by conventional monitors—most notably, atrial fibrillation. 📊 Outperformed extended patches: In patients wearing patch monitors for 7+ days, KardiaMobile 6L caught arrhythmias in 23.9% of patients vs. 9.8% by patches alone. 📱 High quality & ease: 92.3% of 6,251 recordings were clinically interpretable, with 88% of patients reporting higher confidence in capturing symptoms. By empowering patients to record medical-grade, 6-lead ECGs the precise moment symptoms strike, clinicians can close critical diagnostic blind spots and accelerate time-to-treatment. ⏱️💡 📰 Read the full press release: globenewswire.com/news-relea… 📖 Access the published paper in JACC Advances: sciencedirect.com/science/ar… #Cardiology #DigitalHealth #MedTech #Arrhythmia #ECG #HealthTech #JACCAdvances

🎙️ Our founder, @DrDave01, recently joined 𝘛𝘩𝘦 𝘏𝘢𝘳𝘥𝘵𝘦𝘤𝘩 podcast to share: 🚀 𝗧𝗵𝗲 𝗔𝗹𝗶𝘃𝗲𝗖𝗼𝗿 𝗢𝗿𝗶𝗴𝗶𝗻 𝗦𝘁𝗼𝗿𝘆: From a viral video to an industry-defining product. ⚙️ 𝗘𝗻𝗴𝗶𝗻𝗲𝗲𝗿𝗶𝗻𝗴 𝗚𝗿𝗶𝘁: Scaling hardware and navigating regulatory clearances. ⚖️ 𝗧𝗵𝗲 𝗕𝗮𝗹𝗮𝗻𝗰𝗶𝗻𝗴 𝗔𝗰𝘁: Managing direct to consumer business alongside growing clinical partnerships. 💡 𝗙𝗼𝘂𝗻𝗱𝗲𝗿 𝗔𝗱𝘃𝗶𝗰𝗲: Hard-won lessons for those entering the regulated space. 🎧 Listen to the full episode here: open.spotify.com/episode/2lt… #DigitalHealth #Leadership #MedTech #HealthTech #Podcast #Cardiology #Innovation #AliveCor

🏥 For too long, sophisticated medical tools have been locked behind hospital doors—forcing a "waiting room culture" on patients. In a new article for @ChiefHealthExec, AliveCor CEO Priya Abani breaks down how recent CPT code updates for remote patient monitoring (RPM) can shift care from overcrowded hospitals to living rooms nationwide. "Leaders must step up, enact changes, and inform patients about these new possibilities. That's how coverage becomes care." 🔗 Read Priya’s full article to see how expanded RPM coverage will save lives: chiefhealthcareexecutive.com…

𝗡𝗲𝘅𝘁 𝘀𝘁𝗼𝗽: 𝗠𝘂𝗻𝗶𝗰𝗵 𝗳𝗼𝗿 #𝗘𝗦𝗖𝗖𝗼𝗻𝗴𝗿𝗲𝘀𝘀 𝟮𝟬𝟮𝟲! AliveCor will be heading to the @escardio Congress from 𝗔𝘂𝗴𝘂𝘀𝘁 𝟮𝟴-𝟯𝟭. As cardiac care moves toward more flexible, data-driven models, we’re bringing the technology to lead the way. Visit us at Booth DH18 in Hall B2 to experience: ✨ 𝗧𝗵𝗲 𝗖𝗘-𝗺𝗮𝗿𝗸𝗲𝗱 𝗞𝗮𝗿𝗱𝗶𝗮 𝟭𝟮𝗟 𝗘𝗖𝗚 𝗦𝘆𝘀𝘁𝗲𝗺: Our latest innovation in portable diagnostics. Lighter than a smartphone and designed with a unique single-cable design and reduced leadset, it provides medical-grade 12-lead ECG in various care settings. 🏆 𝗡𝗜𝗖𝗘-𝗥𝗲𝗰𝗼𝗺𝗺𝗲𝗻𝗱𝗲𝗱 𝗧𝗲𝗰𝗵𝗻𝗼𝗹𝗼𝗴𝘆: Explore our award-winning Kardia ECG solutions that are already helping clinicians worldwide deliver faster, more efficient cardiac care. To learn more about Kardia 12L, join us for the Digital Health Session on August 29 from 15:30-15:50. See you in Munich! 👋 #ESC2026 #Kardia12L #Cardiology #DigitalHealth #MedTech #AliveCor

In her latest piece for @statnews, our CEO Priya Abani challenges the "fog of skepticism" surrounding medical AI. Asking if AI improves healthcare is like asking if lasers improve surgery—in the hands of a skilled clinician using a validated tool, the answer is a definitive 𝘆𝗲𝘀. Priya highlights life-saving innovations that are already: 🌉 Bridging "healthcare deserts" by bringing diagnostics to the home. 👁️ Spotting cardiac changes imperceptible to the human eye. 🏥 Reducing hospital stays through early physiological detection. 📖 Read Priya’s full perspective: statnews.com/2026/08/06/ai-h… #HealthTech #AI #DigitalHealth #ClinicalAI #Innovation #STATNews #AliveCor

What if detecting a life-threatening cardiac event didn't require a traditional, bulky 12-lead ECG machine? A new case report published in #JACCCaseReports highlights how Kardia 12L—AliveCor’s FDA-cleared, AI-powered 12-lead ECG solution—successfully helped identify Wellens' Syndrome in an asymptomatic patient outside of a traditional clinical setting. Key Highlights: The Case Presentation: An asymptomatic patient with a history of transient chest pain underwent an ECG recording using Kardia 12L, revealing a classic Wellens' Type A pattern. Clinical Accuracy: The Kardia 12L recording matched the hospital's conventional 12-lead ECG, leading to immediate catheterization that identified two 80% LAD blockages requiring stenting. Simplicity at the Point of Need: With just 5 electrodes and a single cable design, Kardia 12L enables fast, intuitive 12-lead ECG acquisition—allowing quick, clinical-grade ECG capture. By eliminating bulky equipment and complex lead placement, Kardia 12L is helping clinicians bridge critical diagnostic gaps, streamline care, and expand access to rapid cardiac evaluation anywhere. 📖 Read the full open-access case report here: sciencedirect.com/science/ar…

🎙️ Listen to our Founder and Chief Medical Officer, @DrDave01, as he shares the story of founding AliveCor and the journey behind Kardia with @ffishkin on 𝘛𝘦𝘤𝘩𝘴𝘵𝘪𝘯𝘢𝘵𝘪𝘰𝘯 podcast. Dr. Dave also shares one of his earliest science experiments: launching spiders in model rockets to see if they could still spin webs afterward. Turns out, space travel and web-building don’t mix. Early lessons in “the cloud.” 🕷️🚀☁️ 🎧Catch the episode here: techstination.com/interview.…

👋 𝗛𝗲𝗹𝗹𝗼 𝗳𝗿𝗼𝗺 𝗗𝗶𝗿𝗲𝗰𝘁 𝗣𝗿𝗶𝗺𝗮𝗿𝘆 𝗖𝗮𝗿𝗲 (𝗗𝗣𝗖) 𝗦𝘂𝗺𝗺𝗶𝘁! 👋 Visit booth 44 for a live demo of the award-winning Kardia 12L. From reducing ECG acquisition time to streamlining workflows and cutting costs, we’re showing how Kardia 12L is a game-changer for physicians and patients alike. 🩺 #DPCSummit #DirectPrimaryCare #Kardia12L #HealthTech #PrimaryCare #Innovation

The transition of cardiac care from the clinic to the home is no longer a distant vision—it’s an imminent reality. 🫀 But as remote monitoring scales, how do we separate critical clinical insights from everyday data noise? AliveCor’s Chief Clinical Officer Dr. Ben Green outlines the core challenges and massive potential of home-based cardiac care in his new KevinMD.com article. He breaks down: The demographic shifts making home care a necessity. 📈 Why legacy tools like the standard 12-lead ECG are facing modern bottlenecks. 🩺 The mandate for clinical-grade data to fuel trusted AI diagnostics. 📊 Dive into the full article here: 🔗 kevinmd.com/2026/07/home-bas… #CardiovascularHealth #AIinHealthcare #PatientCare #AliveCor #RemoteMonitoring

Postoperative atrial fibrillation (POAF) is the most common complication after cardiac surgery—yet continuous rhythm monitoring often stops the moment a patient leaves the hospital. The recently published Society of Thoracic Surgeons (STS) clinical practice guidelines address this critical post-discharge gap. On the AliveCor blog, our Chief Clinical Officer, Dr. Ben Green, breaks down why these new guidelines are a massive call to action for the industry. Discover how patient-driven, medical-grade technology can bridge the gap in post-surgical care and provide the continuous oversight patients deserve. 👇 Read the full piece by Dr. Ben Green here: linkedin.com/pulse/after-why… #DigitalHealth #Cardiology #HealthTech #AliveCor #MedTech

Is it time to shift the conversation from "better AI" to "better signals"? 🧠⚡ A recent independent study published in @Nature serves as a powerful reminder that the ECG still contains critical data we have yet to fully unlock. But to discover those insights, we have to preserve the signal. 🛡️ Here is why expanding beyond a single-lead perspective matters in everyday clinical practice: Overcoming Artifact: When patient movement or noise disrupts one lead, additional simultaneous leads provide a clearer view of the same heartbeat. 🏃‍♂️ Richer Context: More perspectives give physicians improved confidence when evaluating QT and PR intervals, electrical axis, and overall morphology. 🔬 Patient Access: Capturing this medical-grade data at 2 a.m. when symptoms actually occur, rather than waiting for an office visit. 🕒 At AliveCor, this philosophy guided the development of the KardiaMobile 6L Max. Discover @DrDave01’s full take on where ambulatory ECG is heading next. Link to the blog post here: linkedin.com/pulse/future-ec…

We are excited to welcome new distribution partners to the Kardia 12L global network. As adoption of Kardia 12L continues to grow, these partnerships strengthen our ability to deliver advanced ECG technology with local expertise, responsive support, and improved access for clinicians and healthcare organizations worldwide. Together, we are helping more healthcare teams detect cardiac conditions earlier and make informed clinical decisions wherever care is delivered. Welcome to Aeriecura, DocCheck, Finmed Group, Med Surg Solutions, Megasense, OneMedic, Praxisdienst, Quiver, Red Dolphin, Tromiyun Medical Services, and Vital Beats. We look forward to growing together. #Kardia12L #MedTech #GlobalExpansion #HealthcareInnovation #PartnershipAnnouncement #CardiacCare

Global medical costs are facing double-digit spikes. 🌍📈The solution? Moving from reactive to proactive care. In her latest piece for Fast Company Executive Board, our CEO Priya Abani breaks down why Remote Patient Monitoring (RPM) is no longer just a clinical tool—it’s an economic necessity. By catching health events before they happen, RPM has the power to drastically reduce hospitalizations and save billions in healthcare costs nationwide. 🏥❤️ But to get there, health tech leaders must prioritize affordability and accessibility.💡 📰 Read the full article to see how we're working to scale these life-saving technologies: fastcompany.com/91567643/how… #HealthTech #RemoteMonitoring #Cardiology #Innovation #AliveCor #DigitalHealth